BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

342 related articles for article (PubMed ID: 26976495)

  • 1. Caffeine Administration to Prevent Apnea in Very Premature Infants.
    Armanian AM; Iranpour R; Faghihian E; Salehimehr N
    Pediatr Neonatol; 2016 Oct; 57(5):408-412. PubMed ID: 26976495
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prophylactic caffeine to prevent postoperative apnea following general anesthesia in preterm infants.
    Henderson-Smart DJ; Steer P
    Cochrane Database Syst Rev; 2001; (4):CD000048. PubMed ID: 11687065
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prophylactic methylxanthine for preventing of apnea in preterm infants.
    Henderson-Smart DJ; Steer PA
    Cochrane Database Syst Rev; 2000; (2):CD000432. PubMed ID: 10796361
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Influence of prevention of caffeine citrate on cytokine profile and bronchopulmonary dysplasia in preterm infants with apnea.
    Kou C; Han D; Li Z; Wu W; Liu Z; Zhang Y; Gao Z
    Minerva Pediatr; 2020 Apr; 72(2):95-100. PubMed ID: 30961342
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Methylxanthine treatment for apnea in preterm infants.
    Henderson-Smart DJ; Steer P
    Cochrane Database Syst Rev; 2000; (2):CD000140. PubMed ID: 10796304
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Postoperative caffeine for preventing apnea in preterm infants.
    Henderson-Smart DJ; Steer P
    Cochrane Database Syst Rev; 2000; 2001(2):CD000048. PubMed ID: 10796287
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prophylactic methylxanthine for prevention of apnoea in preterm infants.
    Henderson-Smart DJ; De Paoli AG
    Cochrane Database Syst Rev; 2010 Dec; 2010(12):CD000432. PubMed ID: 21154344
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Methylxanthine treatment for apnea in preterm infants.
    Henderson-Smart DJ; Steer P
    Cochrane Database Syst Rev; 2001; (3):CD000140. PubMed ID: 11686952
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Periextubation caffeine in preterm neonates: a randomized dose response trial.
    Steer PA; Flenady VJ; Shearman A; Lee TC; Tudehope DI; Charles BG
    J Paediatr Child Health; 2003; 39(7):511-5. PubMed ID: 12969204
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Caffeine therapy for apnea of prematurity.
    Schmidt B; Roberts RS; Davis P; Doyle LW; Barrington KJ; Ohlsson A; Solimano A; Tin W;
    N Engl J Med; 2006 May; 354(20):2112-21. PubMed ID: 16707748
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High versus low-dose caffeine for apnea of prematurity: a randomized controlled trial.
    Mohammed S; Nour I; Shabaan AE; Shouman B; Abdel-Hady H; Nasef N
    Eur J Pediatr; 2015 Jul; 174(7):949-56. PubMed ID: 25644724
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term effects of caffeine therapy for apnea of prematurity.
    Schmidt B; Roberts RS; Davis P; Doyle LW; Barrington KJ; Ohlsson A; Solimano A; Tin W;
    N Engl J Med; 2007 Nov; 357(19):1893-902. PubMed ID: 17989382
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Caffeine versus theophylline for apnea of prematurity: a randomised controlled trial.
    Skouroliakou M; Bacopoulou F; Markantonis SL
    J Paediatr Child Health; 2009 Oct; 45(10):587-92. PubMed ID: 19751376
    [TBL] [Abstract][Full Text] [Related]  

  • 14. When to start and stop caffeine and why respiratory status matters.
    Davis PG
    Semin Fetal Neonatal Med; 2020 Dec; 25(6):101175. PubMed ID: 33144042
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Early application of caffeine improves white matter development in very preterm infants.
    Liu S; Zhang X; Liu Y; Yuan X; Yang L; Zhang R; Zhang X; Wang X; Xu F; Zhu C
    Respir Physiol Neurobiol; 2020 Oct; 281():103495. PubMed ID: 32679370
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Olfactory stimulation prevents apnea in premature newborns.
    Marlier L; Gaugler C; Messer J
    Pediatrics; 2005 Jan; 115(1):83-8. PubMed ID: 15629985
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Clinical effectiveness of different doses of caffeine for primary apnea in preterm infants].
    Zhao Y; Tian X; Liu G
    Zhonghua Er Ke Za Zhi; 2016 Jan; 54(1):33-6. PubMed ID: 26791921
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum caffeine concentrations in preterm neonates.
    Leon AE; Michienzi K; Ma CX; Hutchison AA
    Am J Perinatol; 2007 Jan; 24(1):39-47. PubMed ID: 17195151
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Academic Performance, Motor Function, and Behavior 11 Years After Neonatal Caffeine Citrate Therapy for Apnea of Prematurity: An 11-Year Follow-up of the CAP Randomized Clinical Trial.
    Schmidt B; Roberts RS; Anderson PJ; Asztalos EV; Costantini L; Davis PG; Dewey D; D'Ilario J; Doyle LW; Grunau RE; Moddemann D; Nelson H; Ohlsson A; Solimano A; Tin W;
    JAMA Pediatr; 2017 Jun; 171(6):564-572. PubMed ID: 28437520
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Aminophylline versus caffeine citrate for apnea and bradycardia prophylaxis in premature neonates.
    Larsen PB; Brendstrup L; Skov L; Flachs H
    Acta Paediatr; 1995 Apr; 84(4):360-4. PubMed ID: 7795341
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.